{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "epsTrailingTwelveMonths": -0.0, "sharesOutstanding": 2162160128, "bookValue": 0.001, "fiftyDayAverage": 0.00192, "fiftyDayAverageChange": 8.000014e-05, "fiftyDayAverageChangePercent": 0.041666742, "twoHundredDayAverage": 0.00463, "twoHundredDayAverageChange": -0.0026299998, "twoHundredDayAverageChangePercent": -0.5680345, "marketCap": 5582120, "priceToBook": 2.0, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "currency": "EUR", "financialCurrency": "AUD", "regularMarketOpen": 0.002, "averageDailyVolume3Month": 1983, "averageDailyVolume10Day": 0, "fiftyTwoWeekLowChange": 0.0015, "fiftyTwoWeekLowChangePercent": 3.0, "fiftyTwoWeekRange": "5.0E-4 - 0.012", "fiftyTwoWeekHighChange": -0.01, "fiftyTwoWeekHighChangePercent": -0.8333333, "fiftyTwoWeekLow": 0.0005, "fiftyTwoWeekHigh": 0.012, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "firstTradeDateMilliseconds": 1101193200000, "priceHint": 4, "marketState": "REGULAR", "regularMarketChange": 0.0015, "regularMarketTime": 1683872400, "regularMarketDayHigh": 0.002, "regularMarketDayRange": "0.002 - 0.002", "regularMarketDayLow": 0.002, "regularMarketVolume": 100000, "regularMarketPreviousClose": 0.0005, "bid": 0.002, "ask": 0.005, "bidSize": 500000, "askSize": 40000, "fullExchangeName": "Frankfurt", "regularMarketChangePercent": 299.99997, "regularMarketPrice": 0.002, "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "esgPopulated": false, "exchange": "FRA", "shortName": "AVECHO BIOTECHN. LTD", "longName": "Avecho Biotechnology Limited", "messageBoardId": "finmb_7668662", "market": "dr_market", "symbol": "OEZ.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "2A Westall Road", "address2": "Unit A8", "city": "Clayton", "state": "VIC", "zip": "3168", "country": "Australia", "phone": "61 3 9002 5000", "fax": "61 3 9002 5000", "website": "https://avecho.com.au", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Avecho Biotechnology Limited, a biotechnology company, develops and commercializes human and animal health related products using its proprietary drug delivery system, Tocopherol Phosphate Mixture in Australia. The company operates through Production and Human Health segments. It also produces and sells TPM and Vital ET products for use in drug delivery and cosmetic formulations. In addition, the company's human health portfolio covers delivery of pharmaceutical products through gels, injectables, and patches. Further, it develops feed additive products to enhance feed efficiency and the health of livestock animals. The company has a collaboration with Lambert Initiative at the University of Sydney for treatment of osteoarthritis. Avecho Biotechnology Limited was incorporated in 1992 and is based in Clayton, Australia.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Paul  Gavin BSc (Hons), Ph.D.", "title": "Chief Exec. Officer", "fiscalYear": 2022, "totalPay": {"raw": 182956, "fmt": "182.96k", "longFmt": "182,956"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Roksan  Libinaki Ph.D.", "title": "Chief Operating Officer", "fiscalYear": 2022, "totalPay": {"raw": 160176, "fmt": "160.18k", "longFmt": "160,176"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Melanie Jaye  Leydin B.Bus, C.A., CA", "age": 49, "title": "Company Sec. & CFO", "yearBorn": 1973, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}